Genetics and Treatment of Inflammatory Bowel Disease

Displaying 1 - 23 of 23CSV
McKay, G. E., Coromilas, A., Liu, L., Shaw, K. S., Murphy, M., Punyamurthy, N., Soltero, K. M. S., Damsky, W., Wanat, K. A., Charrow, A. P., Rosenbach, M., Caplan, A., LaSenna, C. E., Arkin, L., & Shields, B. E. (2025). Interleukin‐12/23 and Interleukin‐23 Inhibitors for the Treatment of Cutaneous Crohn’s Disease: A Case Series From a Multi‐Institutional Registry. JEADV Clinical Practice. Portico. https://doi.org/10.1002/jvc2.615
Publication Date
Yanover, C., Magen-Rimon, R., Voss, E. A., Swerdel, J., Sheahan, A., Hall, N., Park, J., Park, R. W., Lee, K. J., Shin, S. J., Seo, S. I., Lee, K.-J., Falconer, T., Haas, L., Nagy, P., Bowring, M. G., Cook, M., Miller, S., El-Hay, T., … Weisshof, R. (2024). Characteristics and Outcomes of Over a Million Patients with Inflammatory Bowel Disease in Seven Countries: Multinational Cohort Study and Open Data Resource. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-024-08787-x
Publication Date
Sun, J., Yao, J., Olén, O., Halfvarson, J., Bergman, D., Ebrahimi, F., Rosengren, A., Sundström, J., & Ludvigsson, J. F. (2024). Risk of heart failure in inflammatory bowel disease: a Swedish population-based study. European Heart Journal, 45(28), 2493–2504. https://doi.org/10.1093/eurheartj/ehae338
Publication Date
Mao, L., Li, Y., Cui, B., Lu, L., Dou, W., Pylypenko, D., Zhu, J., & Li, H. (2024). Multiparametric MRI for Staging of Bowel Inflammatory Activity in Crohn’s Disease with MUSE-IVIM and DCE-MRI: A Preliminary Study. Academic Radiology, 31(3), 880–888. https://doi.org/10.1016/j.acra.2023.08.028
Publication Date
Eriksson, C., Sun, J., Bryder, M., Bröms, G., Everhov, Å. H., Forss, A., Jernberg, T., Ludvigsson, J. F., & Olén, O. (2024). Impact of inflammatory bowel disease on the risk of acute coronary syndrome: A Swedish Nationwide Cohort Study. Alimentary Pharmacology & Therapeutics, 59(9), 1122–1133. Portico. https://doi.org/10.1111/apt.17932
Publication Date

Ko, H. M. (2024). Histopathological Evaluation of Pouch Neoplasia in IBD and Familial Adenomatous Polyposis. Diseases of the Colon & Rectum, 67(S1), S91–S98. https://doi.org/10.1097/dcr.0000000000003320

Publication Date
Solomon, D. H., Demler, O., Rist, P. M., Santacroce, L., Tawakol, A., Giles, J. T., Liao, K. P., & Bathon, J. M. (2024). Biomarkers of Cardiovascular Risk in Patients With Rheumatoid Arthritis: Results From the TARGET Trial. Journal of the American Heart Association, 13(5). https://doi.org/10.1161/jaha.123.032095
Publication Date
Winter, H., Baldassano, R. N., Pfeffkorn, M. D., Wali, P., Verstraete, S. G., Picoraro, J. A., Washek, M. A., Kumar, N., Mortan, W., Havard- Jr, M., Blystone, L., Trombler, B., Pursley, C., Lin, X., Dillon, S. T., Gu, X., Otu, H. H., Ngo, L., & Libermann, T. A. (2024). P192 Personalizing treatment for predicting response to infliximab in children with Crohn’s disease using proteomic biomarkers. Journal of Crohn’s and Colitis, 18(Supplement_1), i506–i506. https://doi.org/10.1093/ecco-jcc/jjad212.0322
Publication Date
Weisshof, R., Magen-Rimon, R., Voss, E., Swerdel, J., Sheahan, A., Hall, N., Park, J., Park, R. W., Lee, K. J., Sung, J. S., Seo, S. I., Lee, K. J., Falconer, T., Haas, L., Nagy, P., Bowring, M., Cook, M., Miller, S., El-Hay, T., … Yanover, C. (2024). P1156 Characteristics and outcomes of over a million Inflammatory Bowel Disease patients in seven countries: a multinational cohort study. Journal of Crohn’s and Colitis, 18(Supplement_1), i2066–i2066. https://doi.org/10.1093/ecco-jcc/jjad212.1286
Publication Date
Sun, J., Roelstraete, B., Svennberg, E., Halfvarson, J., Sundström, J., Forss, A., Olén, O., & Ludvigsson, J. F. (2023). Long-term risk of arrhythmias in patients with inflammatory bowel disease: A population-based, sibling-controlled cohort study. PLOS Medicine, 20(10), e1004305. https://doi.org/10.1371/journal.pmed.1004305
Publication Date
Gnanapandithan, K., Mourad, F. H., Shen, B., Farraye, F. A., & Hashash, J. G. (2023). S1025 Pouch Outcomes in Patients With Inflammatory Bowel Disease and Ileal Pouch Anal Anastomosis Who Undergo Pelvic Radiation. American Journal of Gastroenterology, 118(10S), S778–S778. https://doi.org/10.14309/01.ajg.0000953740.28708.2a
Publication Date
Lee, K. E., Aziz, Z., Vyas, C., Barrett, C., Hembree, A., Gray, J., Suek, N., Shih, H., Artin, M., Sehgal, P., Faye, A. S., & Shen, B. (2023). S1129 Impact of Gastrointestinal PCR in Patients With Ileal Pouch-Anal Anastomosis. American Journal of Gastroenterology, 118(10S), S862–S864. https://doi.org/10.14309/01.ajg.0000954156.18929.d1
Publication Date
Choy, A. M., Ko, H. M., Kelly, M. R., Bowman, C. A., Green, D., & Freedberg, D. E. (2023). Hiding in Plain Sight. Gastroenterology, 165(3), e14–e16. https://doi.org/10.1053/j.gastro.2023.02.038
Publication Date
Panganiban, R. P., Tuan, A., Hart, M., Pelton, M., Mikhail, D., Akhtar, S., Bogale, K., Deiling, S., Zhou, S., Coates, M. D., Yochum, G. S., & Koltun, W. (2023). Pyoderma Gangrenosum Is Associated With Increased Risk of Inflammatory Pouch-Related Complications: A Retrospective Cohort Study. Crohn’s & Colitis 360, 5(3). https://doi.org/10.1093/crocol/otad024
Publication Date
Bergman, D., Khalili, H., Lebwohl, B., Roelstraete, B., Green, P. H. R., & Ludvigsson, J. F. (2023). Celiac disease and risk of microscopic colitis: A nationwide population‐based matched cohort study. United European Gastroenterology Journal, 11(2), 189–201. Portico. https://doi.org/10.1002/ueg2.12374
Publication Date
Sun, J., Fang, F., Olén, O., Song, M., Halfvarson, J., Roelstraete, B., Khalili, H., & Ludvigsson, J. F. (2023). Long-term risk of inflammatory bowel disease after endoscopic biopsy with normal mucosa: A population-based, sibling-controlled cohort study in Sweden. PLOS Medicine, 20(2), e1004185. https://doi.org/10.1371/journal.pmed.1004185
Publication Date
Sehgal, P., Su, S., Zech, J., Nobel, Y., Luk, L., Economou, I., Shen, B., Kiran, P., & Freedberg, D. (2023). P835 Visceral adiposity independently predicts time to flare in inflammatory bowel disease, but BMI does not. Journal of Crohn’s and Colitis, 17(Supplement_1), i964–i965. https://doi.org/10.1093/ecco-jcc/jjac190.0965
Publication Date
Kayal, M., Tankelevich, M., Guo, Y., Fischer, J., Jimenez, D., Canales-Herrerias, P., Livanos, A., Colombel, J. F., Dubinsky, M., Faith, J., Ko, H., & Mehandru, S. (2023). DOP70 Crohn’s Disease Like Inflammation of The Pouch is a Distinct Type of Pouchitis. Journal of Crohn’s and Colitis, 17(Supplement_1), i145–i146. https://doi.org/10.1093/ecco-jcc/jjac190.0110
Publication Date
Jairath, V., Feagan, B. G., Silverberg, M. S., Danese, S., Gionchetti, P., Löwenberg, M., Bressler, B., Ferrante, M., Hart, A., Lindner, D., Escher, A., Jones, S., Shen, B., & Travis, S. (2023). OP08 Mucosal healing with vedolizumab in inflammatory bowel disease patients with chronic pouchitis: Evidence from EARNEST, a randomized, double-blind, placebo-controlled trial. Journal of Crohn’s and Colitis, 17(Supplement_1), i13–i14. https://doi.org/10.1093/ecco-jcc/jjac190.0008
Publication Date
Lee, K. E., Lim, F., Faye, A., Hur, C., & Shen, B. (2022). S1087 Cost-Effectiveness of Endoscopic Stricturotomy versus Resection Surgery for Crohn’s Disease Strictures. American Journal of Gastroenterology, 117(10S), e791–e791. https://doi.org/10.14309/01.ajg.0000860988.64422.3a
Publication Date
Shi, C., Dawulieti, J., Shi, F., Yang, C., Qin, Q., Shi, T., Wang, L., Hu, H., Sun, M., Ren, L., Chen, F., Zhao, Y., Liu, F., Li, M., Mu, L., Liu, D., Shao, D., Leong, K. W., & She, J. (2022). A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease. Science Advances, 8(4). https://doi.org/10.1126/sciadv.abj2372
Publication Date
Yu, K., Faye, A., Wen, T., Guglielminotti, J., Huang, Y., Wright, J. D., D’Alton, M. E., & Friedman, A. M. (2022). Trends in and Outcomes during Delivery Hospitalizations with Inflammatory Bowel Disease. American Journal of Obstetrics and Gynecology, 226(1), S363–S364. https://doi.org/10.1016/j.ajog.2021.11.610
Publication Date